THE LIMEHOUSE PRACTICE — All Prescriptions & Medications — Page 10
Practice Code: F84054 | LONDON, E14 8HQ
Showing results 451-500 of 565
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Erythromycin | 19 | 1,395 | £651 | +39.9% ▲ |
| Diclofenac sodium | 19 | 1,850 | £1.3K | -20.7% ▼ |
| Sodium fusidate | 19 | 540 | £80 | +244.0% ▲ |
| 19 | 2,301 | £142 | -77.7% ▼ | |
| 19 | 1,356 | £110 | -6.0% ▼ | |
| 19 | 494 | £1.1K | -52.4% ▼ | |
| Moxonidine | 18 | 2,128 | £268 | -67.7% ▼ |
| Erythromycin ethylsuccinate | 18 | 2,570 | £449 | -22.9% ▼ |
| Metformin hydrochloride/sitagliptin | 18 | 2,380 | £427 | -51.9% ▼ |
| RtS 1.5 - 1.6 kcal/ml milkshake with fibre (0913011) | 18 | 448.0K | £6.0K | +35.4% ▲ |
| Pimecrolimus | 18 | 940 | £554 | +6.3% ▲ |
| Co-magaldrox (Magnesium/aluminium hydroxide) | 17 | 8,500 | £48 | +109.8% ▲ |
| Salmeterol | 17 | 38 | £1.0K | -29.3% ▼ |
| Acrivastine | 17 | 1,260 | £371 | +38.0% ▲ |
| Amantadine hydrochloride | 17 | 3,972 | £3.3K | -39.0% ▼ |
| Water for injection | 17 | 370 | £109 | -49.7% ▼ |
| Ready to serve infant formula, high energy (0913104) | 17 | 269.6K | £3.3K | +53.9% ▲ |
| Medicated stockings | 17 | 84 | £318 | +152.3% ▲ |
| 17 | 2,280 | £3.9K | -19.7% ▼ | |
| 17 | 36 | £566 | +122.3% ▲ | |
| 17 | 66 | £873 | +30.0% ▲ | |
| Sennosides | 16 | 6,950 | £133 | -48.2% ▼ |
| Ticagrelor | 16 | 1,984 | £1.9K | -81.2% ▼ |
| Diphenhydramine hydrochloride | 16 | 112 | £30 | +23.2% ▲ |
| Dexamethasone | 16 | 707 | £51 | -48.7% ▼ |
| Triptorelin | 16 | 16 | £3.3K | -24.1% ▼ |
| Diclofenac sodium | 16 | 1,600 | £83 | +50.4% ▲ |
| Atropine sulfate | 16 | 320 | £261 | +25.6% ▲ |
| Travoprost | 16 | 45 | £29 | -66.0% ▼ |
| Timolol and brimonidine | 16 | 195 | £508 | +14.0% ▲ |
| Dexamethasone sodium metasulphobenzoate | 16 | 136 | £121 | +115.3% ▲ |
| Sodium chloride | 16 | 3,212 | £1.9K | -46.2% ▼ |
| Tars | 16 | 3,200 | £216 | +90.9% ▲ |
| 16 | 106 | £289 | -34.0% ▼ | |
| Balsalazide sodium | 15 | 2,666 | £594 | +0.7% vs avg |
| Nebivolol | 15 | 812 | £123 | -85.8% ▼ |
| Dabigatran etexilate | 15 | 900 | £744 | -71.0% ▼ |
| Aclidinium bromide/formoterol | 15 | 15 | £463 | -57.3% ▼ |
| Agomelatine | 15 | 532 | £224 | -15.3% ▼ |
| Tapentadol | 15 | 700 | £573 | -63.6% ▼ |
| Dapagliflozin/metformin | 15 | 2,520 | £1.6K | -65.8% ▼ |
| 15 | 1,380 | £3.0K | -14.9% ▼ | |
| 15 | 15 | £327 | +74.7% ▲ | |
| 15 | 1,150 | £226 | -41.8% ▼ | |
| 15 | 850 | £3.1K | -60.1% ▼ | |
| Doxylamine succinate/pyridoxine hydrochloride | 14 | 840 | £1.2K | +26.9% ▲ |
| Betamethasone sodium phosphate | 14 | 760 | £102 | +13.9% ▲ |
| Alfuzosin hydrochloride | 14 | 1,568 | £260 | -80.4% ▼ |
| Azelastine hydrochloride | 14 | 350 | £159 | +24.9% ▲ |
| Other sunscreening preparations | 14 | 2,385 | £209 | +78.6% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.